CN116559102A - Rapid detection method of glutathione and cysteine - Google Patents
Rapid detection method of glutathione and cysteine Download PDFInfo
- Publication number
- CN116559102A CN116559102A CN202310836084.1A CN202310836084A CN116559102A CN 116559102 A CN116559102 A CN 116559102A CN 202310836084 A CN202310836084 A CN 202310836084A CN 116559102 A CN116559102 A CN 116559102A
- Authority
- CN
- China
- Prior art keywords
- hemin
- glutathione
- cysteine
- tmb
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title claims abstract description 92
- 229960003180 glutathione Drugs 0.000 title claims abstract description 46
- 108010024636 Glutathione Proteins 0.000 title claims abstract description 41
- 235000018417 cysteine Nutrition 0.000 title claims abstract description 31
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title claims abstract description 31
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 title claims abstract description 27
- 238000001514 detection method Methods 0.000 title abstract description 42
- 229940025294 hemin Drugs 0.000 claims abstract description 68
- 230000005764 inhibitory process Effects 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims description 17
- 238000002835 absorbance Methods 0.000 claims description 16
- 102000004316 Oxidoreductases Human genes 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 108090000854 Oxidoreductases Proteins 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 10
- 239000007974 sodium acetate buffer Substances 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 238000012417 linear regression Methods 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 34
- 239000000463 material Substances 0.000 abstract description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract description 5
- 238000011896 sensitive detection Methods 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 11
- 238000012795 verification Methods 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 239000007850 fluorescent dye Substances 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 239000007806 chemical reaction intermediate Substances 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000002516 radical scavenger Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000003197 catalytic effect Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 229940123457 Free radical scavenger Drugs 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002795 fluorescence method Methods 0.000 description 3
- 230000005298 paramagnetic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- XYJODUBPWNZLML-UHFFFAOYSA-N 5-ethyl-6-phenyl-6h-phenanthridine-3,8-diamine Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2N(CC)C1C1=CC=CC=C1 XYJODUBPWNZLML-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/10—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using electron paramagnetic resonance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- High Energy & Nuclear Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明一种谷胱甘肽和半胱氨酸快速检测方法,基于Fe‑N‑C@Hemin纳米酶活性,利用巯基小分子对Fe‑N‑C@Hemin的类氧化酶活性的抑制原理,验证了Fe‑N‑C@Hemin纳米酶对谷胱甘肽(GSH)及半胱氨酸(Cys)的检测能力;以Fe‑N‑C@Hemin为传感器主要材料,构建了基于该纳米酶的生物传感器,用以快速、灵敏地检测谷胱甘肽及半胱氨酸。
A rapid detection method for glutathione and cysteine of the present invention is based on the activity of Fe-N-C@Hemin nano-enzymes, and utilizes the principle of inhibition of the oxidase-like activity of Fe-N-C@Hemin by small molecules of sulfhydryl groups. The detection ability of Fe‑N‑C@Hemin nanozyme to glutathione (GSH) and cysteine (Cys) was verified; with Fe‑N‑C@Hemin as the main material of the sensor, a nanozyme based on the A biosensor for the rapid and sensitive detection of glutathione and cysteine.
Description
技术领域technical field
本发明属于食品安全检测技术领域,具体涉及一种谷胱甘肽及半胱氨酸的快速检测方法。The invention belongs to the technical field of food safety detection, and in particular relates to a rapid detection method for glutathione and cysteine.
背景技术Background technique
半胱氨酸是生物体内一种常见氨基酸,也是巯基小分子的代表物质,在多种生理活动中起重要作用,包括信号传递、蛋白质生物合成、磷脂代谢等,半胱氨酸水平失衡会导致各种组织的损害。谷胱甘肽则是一种内源性活性肽,是生命系统中最常见的生物硫醇,由谷氨酸、半胱氨酸及甘氨酸组成,存在于人体内的每个细胞当中,它作为一种抗氧化剂,在调节氧化还原平衡、维持免疫系统、细胞信号转导、维持蛋白质结构、基因转录调控等过程起到了重要作用。目前,谷胱甘肽水平已被证明是检测皮肤、血液、癌症、肝损伤、糖尿病和阿兹海默症等疾病的关键指标。谷胱甘肽在人体中可以由半胱氨酸、谷氨酸和甘氨酸内源性形成,但人体内源形成的谷胱甘肽含量远不足以满足人体正常生理活动的需要。此外,谷胱甘肽在衰老、应激和疾病导致活性氧增加的情况下会加速氧化,而且体内的谷胱甘肽还会被新陈代谢和排泄所消耗。当谷胱甘肽等内源性抗氧化剂水平降低时,人体极易患病,所以需要从食物或补充剂中获取谷胱甘肽。准确定量食品中的谷胱甘肽水平对于日常谷胱甘肽的补充提供了重要参考意义。Cysteine is a common amino acid in organisms, and it is also a representative substance of small sulfhydryl molecules. It plays an important role in various physiological activities, including signal transmission, protein biosynthesis, phospholipid metabolism, etc. The imbalance of cysteine level will lead to Damage to various tissues. Glutathione is an endogenous active peptide, which is the most common biothiol in the living system. It is composed of glutamic acid, cysteine and glycine, and exists in every cell in the human body. It acts as An antioxidant that plays an important role in regulating redox balance, maintaining the immune system, cell signal transduction, maintaining protein structure, gene transcription regulation and other processes. Currently, glutathione levels have been shown to be a key indicator of diseases such as skin, blood, cancer, liver damage, diabetes and Alzheimer's disease. Glutathione can be formed endogenously from cysteine, glutamic acid and glycine in the human body, but the content of glutathione formed in the human body is far from enough to meet the needs of normal physiological activities of the human body. In addition, glutathione will accelerate oxidation when aging, stress and disease lead to increased active oxygen, and glutathione in the body will be consumed by metabolism and excretion. When the level of endogenous antioxidants such as glutathione is low, the human body is very susceptible to disease, so it is necessary to obtain glutathione from food or supplements. Accurate quantification of glutathione levels in food provides an important reference for daily glutathione supplementation.
目前,针对谷胱甘肽的检测主要仍集中于医学领域,在食品领域的谷胱甘肽检测方法和相关研究较少,已有研究表明巯基分子可以结合Fe-N-C单原子纳米酶并抑制纳米酶的活性,因此,本发明探究半胱氨酸及谷胱甘肽对以血红素(Hemin)作为有机铁来源的Fe-N-C@Hemin纳米材料OXD活性的抑制能力,对谷胱甘肽在血清和食品两类基质中检测的性能进行研究,不仅能够为人体谷胱甘肽相关的疾病诊断提供一种检测手段,也能为含有谷胱甘肽的功能性食品提供一定指导价值。此外,利用氧化酶活性还能够避免以往研究中由于POD活性所需的H2O2易分解导致的稳定性不足的缺陷。At present, the detection of glutathione is still mainly concentrated in the medical field, and there are few detection methods and related researches in the food field. Studies have shown that sulfhydryl molecules can bind Fe-NC single-atom nanozymes and inhibit nano-enzymes. Enzyme activity, therefore, the present invention explores the inhibitory ability of cysteine and glutathione to the OXD activity of Fe-NC@Hemin nanomaterials with heme (Hemin) as the source of organic iron, and the effect on glutathione in serum The research on the performance of detection in two types of matrices, food and food, can not only provide a detection method for the diagnosis of human glutathione-related diseases, but also provide a certain guiding value for functional foods containing glutathione. In addition, the use of oxidase activity can also avoid the defect of insufficient stability caused by the easy decomposition of H2O2 required for POD activity in previous studies.
发明内容Contents of the invention
为了实现对谷胱甘肽及半胱氨酸的快速检测,利用Fe-N-C@Hemin的类氧化酶活性及巯基对其类氧化酶活性的抑制,实现了对谷胱甘肽及半胱氨酸的快速检测。In order to realize the rapid detection of glutathione and cysteine, the oxidase-like activity of Fe-N-C@Hemin and the inhibition of its oxidase-like activity by sulfhydryl groups were used to realize the detection of glutathione and cysteine. rapid detection.
首先,本发明提供Fe-N-C@Hemin类氧化酶活性机理检测方法:First, the present invention provides a method for detecting the activity mechanism of Fe-N-C@Hemin oxidases:
所述检测方法包括:(1)需氧性验证;(2)电子顺磁能谱法验证;(3)反应中间体特异性荧光探针检测;(4)活性氧指示剂结合自由基清除剂验证主要反应中间体。The detection method includes: (1) verification of aerobicity; (2) verification of electron paramagnetic energy spectroscopy; (3) detection of specific fluorescent probes for reaction intermediates; (4) verification of active oxygen indicator combined with free radical scavenger The main reaction intermediate.
所述需氧性验证为:首先在0.1 mg/mL Fe-N-C@Hemin溶液中加入10 uL TMB,分别通入空气和氮气,利用紫外分光光度计测得652 nm处吸光度差异,若差异较大,说明该反应需要氧气参与;The verification of aerobicity is as follows: firstly add 10 uL TMB to the 0.1 mg/mL Fe-N-C@Hemin solution, pass air and nitrogen respectively, measure the difference in absorbance at 652 nm with a UV spectrophotometer, if the difference is large , indicating that the reaction requires the participation of oxygen;
所述电子顺磁能谱法验证为:利用电子顺磁能谱,以5,5-二甲基-1-氧化吡咯啉(DMPO)作为特异性探针捕获催化TMB显色过程中的反应中间体,测得共振谱图,分析其特征峰,以判断反应中间体的存在;The electron paramagnetic spectroscopy method is verified as follows: using electron paramagnetic spectroscopy, using 5,5-dimethyl-1-pyrroline oxide (DMPO) as a specific probe to capture the reaction intermediate in the process of catalytic TMB color development, Measure the resonance spectrum and analyze its characteristic peaks to judge the existence of reaction intermediates;
所述反应中间体特异性荧光探针检测为:选择三种荧光探针(TA、SOGC、DHE)作为Fe-N-C@Hemin催化TMB氧化的自由基指示剂,分别用于检测•OH、1O2、;The specific fluorescent probe detection of the reaction intermediate is as follows: three kinds of fluorescent probes (TA, SOGC, DHE) are selected as free radical indicators for the oxidation of TMB catalyzed by Fe-NC@Hemin, which are used to detect OH, 1 O 2 . ;
所述活性氧指示剂结合自由基清除剂验证主要反应中间体方法,包括(1)荧光法;(2)比色法。荧光法为用活性氧荧光探针DCFH-DA作为标记信号,分别加入•OH、1O2、对应的三种自由基清除剂:异丙醇、叠氮化钠和超氧化物歧化酶,分析加入对应清除剂后荧光的减弱程度;比色法为在分别含有三种自由基清除剂的溶液中加入Fe-N-C@Hemin与TMB,分析加入对应清除剂后652 nm处吸光度的减弱程度。The methods for verifying the main reaction intermediates of the active oxygen indicator combined with the free radical scavenger include (1) fluorescence method; (2) colorimetric method. The fluorescence method is to use the active oxygen fluorescent probe DCFH-DA as the labeling signal, add OH, 1 O 2 , The corresponding three free radical scavengers: isopropanol, sodium azide and superoxide dismutase, analyze the weakening degree of fluorescence after adding the corresponding scavengers; Add Fe-NC@Hemin and TMB to the solution, and analyze the weakening degree of the absorbance at 652 nm after adding the corresponding scavenger.
本发明提供的Fe-N-C@Hemin纳米酶相较于Fe-N-C无机纳米酶具有更为优异的OXD活性:Compared with Fe-N-C inorganic nanozyme, the Fe-N-C@Hemin nanozyme provided by the present invention has more excellent OXD activity:
所述OXD活性利用类氧化酶动力学参数比较,Fe-N-C的Km值为0.09022 mM,Fe-N-C@Hemin的Km为0.05905 mM。The Km value of Fe-N-C was 0.09022 mM, and the Km value of Fe-N-C@Hemin was 0.05905 mM compared with the oxidase-like kinetic parameters of the OXD activity.
本发明提供Fe-N-C@Hemin的类氧化酶活性推测机理。The present invention provides a speculative mechanism for the oxidase-like activity of Fe-N-C@Hemin.
所述机理基于前述实验验证,推测Fe-N-C@Hemin类氧化酶催化机理如下:Fe-N-C@Hemin能够催化其表面所吸附的溶解氧,产生,/>在水溶液中极不稳定,会迅速反应生成H2O2和1O2,H2O2则与/>反应生成•OH,此外,Fe-N-C@Hemin也可由类芬顿反应直接催化H2O2生成/>和•OH。The mechanism is based on the aforementioned experimental verification, and it is speculated that the catalytic mechanism of Fe-NC@Hemin oxidase is as follows: Fe-NC@Hemin can catalyze the dissolved oxygen adsorbed on its surface to produce , /> Extremely unstable in aqueous solution, it will react quickly to form H 2 O 2 and 1 O 2 , and H 2 O 2 and /> The reaction generates OH. In addition, Fe-NC@Hemin can also directly catalyze the generation of H 2 O 2 by Fenton-like reaction/> and •OH.
基于上述的机理发现,本发明开发领用了Fe-N-C@Hemin在半胱氨酸或谷胱甘肽的快速检测中的应用,具体为:Based on the above mechanism discovery, the present invention develops and adopts the application of Fe-N-C@Hemin in the rapid detection of cysteine or glutathione, specifically:
本发明的第一方面提供了Fe-N-C@Hemin在作为氧化还原酶的应用。The first aspect of the present invention provides the application of Fe-N-C@Hemin as an oxidoreductase.
在具体的实施方式中,所述的应用于检测谷胱甘肽或半胱氨酸的含量。In a specific embodiment, the method is used to detect the content of glutathione or cysteine.
本发明的第二个方面是提供一种特异性检测谷胱甘肽或半胱氨酸的试剂盒,所述的试剂盒包括:A second aspect of the present invention provides a kit for specifically detecting glutathione or cysteine, said kit comprising:
Fe-N-C@Hemin、TMB、醋酸钠缓冲液。Fe-N-C@Hemin, TMB, sodium acetate buffer.
在一个具体的实施方式中,根所述试剂盒的其中Fe-N-C@Hemin的工作浓度为20~50 μg/mL;TMB的工作浓度为0.2~0.5 mM;醋酸钠缓冲液的pH为3~5。In a specific embodiment, according to the kit, the working concentration of Fe-N-C@Hemin is 20~50 μg/mL; the working concentration of TMB is 0.2~0.5 mM; the pH of the sodium acetate buffer is 3~50 μg/mL; 5.
本发明的第三个方面是利用第二方面所述的试剂盒在检测谷胱甘肽或半胱氨酸含量中的应用.The third aspect of the present invention is the use of the kit described in the second aspect in the detection of glutathione or cysteine content.
在一个具体的实施方式中,其中具体应用方法为:In a specific embodiment, wherein the specific application method is:
1)将待测样品与醋酸钠缓冲液混合,二者体积比为1:8~10;1) Mix the sample to be tested with sodium acetate buffer, the volume ratio of the two is 1:8~10;
2)加入Fe-N-C@Hemin单原子纳米酶,再加入TMB反应2) Add Fe-N-C@Hemin single-atom nanozyme, and then add TMB reaction
3)测定其652 nm处吸光度,计算抑制率,构建线性回归方程,计算浓度。3) Measure the absorbance at 652 nm, calculate the inhibition rate, construct a linear regression equation, and calculate the concentration.
优选的,其中步骤2),Fe-N-C@Hemin的工作浓度为20~50 μg/mL;TMB的工作浓度为0.2~0.5 mM;醋酸钠缓冲液的pH为3~5。Preferably, in step 2), the working concentration of Fe-N-C@Hemin is 20-50 μg/mL; the working concentration of TMB is 0.2-0.5 mM; the pH of the sodium acetate buffer is 3-5.
更优选的,其中步骤2)反应时间为10~20 min;反应pH值为3~5。More preferably, the reaction time of step 2) is 10-20 min; the reaction pH is 3-5.
再另外一个具体的实施方式,其中所述抑制率计算公式为(A0-A)/A0×100,其中A0为不添加待测样品的一组。Yet another specific embodiment, wherein the formula for calculating the inhibition rate is (A 0 -A)/A 0 ×100, wherein A 0 is a group without adding the sample to be tested.
在另外一个具体的实施方式中,所述的样品为食品或血清,其中,当样本为血清时,所述的应用为非诊断目的的应用。In another specific embodiment, the sample is food or serum, and when the sample is serum, the application is for non-diagnostic purposes.
Fe-N-C@Hemin借由上述技术方案,本发明至少具有下列优点及有益效果:Fe-N-C@Hemin With the above technical solution, the present invention has at least the following advantages and beneficial effects:
本发明通过Fe-N-C@Hemin纳米酶建立一种用于谷胱甘肽及半胱氨酸的比色检测方法。首先,验证了Fe-N-C@Hemin的类氧化酶活性及其机理。其次,根据Fe-N-C@Hemin优异的OXD活性,利用巯基对Fe-N-C@Hemin活性的抑制,构建了比色生物传感器用于检测Cys和GSH,且在血清和食品基质中均具有较好的回收率,说明该传感器在实际样品检测中的可行性。The invention establishes a colorimetric detection method for glutathione and cysteine through Fe-N-C@Hemin nanozyme. First, the oxidase-like activity and mechanism of Fe-N-C@Hemin were verified. Secondly, based on the excellent OXD activity of Fe-N-C@Hemin, a colorimetric biosensor was constructed for the detection of Cys and GSH by utilizing the inhibition of sulfhydryl groups on the activity of Fe-N-C@Hemin, and it has good activity in both serum and food matrices. The recovery rate indicates the feasibility of the sensor in actual sample detection.
与现有方法相比,本发明至少可实现如下有益效果之一:Compared with existing methods, the present invention can achieve at least one of the following beneficial effects:
(1)本发明所述检测方法基于Fe-N-C@Hemin纳米酶优异的类氧化酶活性,反应迅速,在20 min内即可完成全部反应,得到检测结果,与传统检测方法相比,检测时间更快,满足快速检测需求。利用肉眼观察即可初步定性,利用652 nm处吸光度的检测能够准确、快速的反映定量结果。(1) The detection method of the present invention is based on the excellent oxidase-like activity of Fe-N-C@Hemin nanozyme, and the reaction is rapid. The entire reaction can be completed within 20 minutes, and the detection result can be obtained. Compared with the traditional detection method, the detection time is shorter Faster to meet the needs of rapid detection. It can be preliminarily qualified by naked eye observation, and the detection of absorbance at 652 nm can accurately and quickly reflect the quantitative results.
(2)本发明检测特异性较好,利用食品及血清中常出现的金属离子、蛋白组分以及糖类,分析所述检测方法对于半胱氨酸及谷胱甘肽的特异性检测能力,结果表明该方法能够特异性识别半胱氨酸及谷胱甘肽,满足特异性检测需求。(2) The detection specificity of the present invention is good, and the metal ions, protein components and sugars that often appear in food and serum are used to analyze the specific detection ability of the detection method for cysteine and glutathione, and the results It shows that the method can specifically recognize cysteine and glutathione, meeting the specific detection requirements.
(3)操作简便:仅利用纳米酶材料及TMB即可完成检测,操作步骤简单,避免了繁琐的步骤,能够以最少的操作步骤获得检测结果。(3) Easy operation: the detection can be completed only by using nanozyme materials and TMB, the operation steps are simple, avoiding cumbersome steps, and the detection results can be obtained with the least operation steps.
附图说明Description of drawings
图1为Fe-N-C@Hemin的类氧化酶性质:图1A为单原子纳米酶模拟氧化酶原理图;图1B为不同体系下紫外-可见吸收光谱。Figure 1 shows the oxidase-like properties of Fe-N-C@Hemin: Figure 1A is the schematic diagram of single-atom nanozyme simulating oxidase; Figure 1B is the UV-Vis absorption spectrum under different systems.
图2为Fe-N-C和Fe-N-C@Hemin纳米酶类氧化酶动力学参数。图2A为Fe-N-C的Michaelis-Menten方程;图2B为Fe-N-C@Hemin的Michaelis-Menten方程(底物为 TMB),插图为 Lineweaver-Burk 曲线;图2C为酶活力SA。Figure 2 shows the kinetic parameters of Fe-N-C and Fe-N-C@Hemin nanozyme oxidase. Figure 2A is the Michaelis-Menten equation of Fe-N-C; Figure 2B is the Michaelis-Menten equation of Fe-N-C@Hemin (substrate is TMB), the inset is the Lineweaver-Burk curve; Figure 2C is the enzyme activity SA.
图3为Fe-N-C@Hemin类氧化酶活性催化机理研究。图3A空气和氮气气氛下的紫外-可见光谱;图3B空气和氮气气氛下的652 nm吸光度.Figure 3 is a study on the catalytic mechanism of Fe-N-C@Hemin oxidase activity. Figure 3A UV-Vis spectra under air and nitrogen atmosphere; Figure 3B Absorbance at 652 nm under air and nitrogen atmosphere.
图4为三种荧光探针检测反应中间体荧光光谱图。图4A对苯二甲酸;图4B单线态氧绿色荧光探针;图4C二氢乙锭。Fig. 4 is the fluorescence spectrum diagram of the detection reaction intermediate of three kinds of fluorescent probes. Figure 4A terephthalic acid; Figure 4B singlet oxygen green fluorescent probe; Figure 4C dihydroethidium.
图5为电子顺磁共振谱图, 图5A:•OH的特征峰;图5B:1O2特征峰;图5C:的特征峰。Figure 5 is the electron paramagnetic resonance spectrum, Figure 5A: the characteristic peak of OH; Figure 5B: the characteristic peak of 1 O 2 ; Figure 5C: characteristic peaks.
图6为三种自由基清除剂处理下的荧光比率图6A与吸光度图图6B;F0为未加自由基清除剂时DCFH-DA与Fe-N-C@Hemin在525 nm处的荧光强度。Fig. 6 is the fluorescence ratio Fig. 6A and the absorbance diagram Fig. 6B under the treatment of three radical scavengers; F 0 is the fluorescence intensity of DCFH-DA and Fe-NC@Hemin at 525 nm without adding radical scavengers.
图7为Fe-N-C@Hemin的类氧化酶机制。Figure 7 shows the oxidase-like mechanism of Fe-N-C@Hemin.
图8为传感体系优化结果,图8A: Fe-N-C@Hemin浓度;图8B:TMB浓度;图8C:反应pH值;图8D:反应时间。Figure 8 shows the optimization results of the sensing system, Figure 8A: Fe-N-C@Hemin concentration; Figure 8B: TMB concentration; Figure 8C: reaction pH value; Figure 8D: reaction time.
图9为传感体系对谷胱甘肽及半胱氨酸的特异性。Figure 9 shows the specificity of the sensing system to glutathione and cysteine.
图10为谷胱甘肽(图10A)及半胱氨酸(图10B)检测灵敏度。Figure 10 shows the detection sensitivity of glutathione (Figure 10A) and cysteine (Figure 10B).
具体实施方式Detailed ways
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用原料均为市售商品。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
实施例1 Fe-N-C@Hemin类氧化酶活性机理的验证Example 1 Verification of the activity mechanism of Fe-N-C@Hemin-like oxidases
1、实验材料1. Experimental materials
3,3’,5,5’-四甲基联苯胺(TMB)、对苯二甲酸、二氢乙锭、单线态氧绿色荧光探针、2',7'-二氯二氢荧光素二乙酸酯购自市售产品。3,3',5,5'-tetramethylbenzidine (TMB), terephthalic acid, dihydroethidium, singlet oxygen green fluorescent probe, 2',7'-dichlorodihydrofluorescein di Acetate was purchased from commercially available products.
2、Fe-N-C@Hemin类氧化酶性质验证2. Verification of Fe-N-C@Hemin-like oxidase properties
为了研究纳米材料的氧化酶活性,对两种材料加入TMB探究其在652 nm处的吸光度。如图1所示,当只有Fe-N-C和Fe-N-C@Hemin存在的时候,均不显色,在652 nm处并未出现明显的峰值,说明在该体系中没有发生氧化反应。当在体系内加入TMB的时候,两种纳米酶均出现明显峰值,Fe-N-C和Fe-N-C@Hemin在652 nm处的吸光值分别为1.088和1.626,且Fe-N-C@Hemin在652 nm处的吸光值高于Fe-N-C在652 nm处的吸光值,表明Fe-N-C@Hemin具有氧化酶活性,能够将TMB氧化为oxTMB,且氧化能力高于Fe-N-C纳米酶。以上结果证明,Fe-N-C@Hemin纳米酶具有优异的类氧化物酶活性。In order to study the oxidase activity of nanomaterials, TMB was added to the two materials to explore their absorbance at 652 nm. As shown in Figure 1, when only Fe-N-C and Fe-N-C@Hemin exist, there is no color development, and there is no obvious peak at 652 nm, indicating that no oxidation reaction occurs in this system. When TMB was added to the system, both nanozymes had obvious peaks, the absorbance values of Fe-N-C and Fe-N-C@Hemin at 652 nm were 1.088 and 1.626, respectively, and Fe-N-C@Hemin was at 652 nm The absorbance value of Fe-N-C@Hemin is higher than that of Fe-N-C at 652 nm, indicating that Fe-N-C@Hemin has oxidase activity, which can oxidize TMB to oxTMB, and the oxidation ability is higher than that of Fe-N-C nanozyme. The above results prove that Fe-N-C@Hemin nanozyme has excellent oxidase-like activity.
通过Michaelis-Menten方程拟合两种纳米酶的酶动力学参数,结果如图2所示,Fe-N-C的米氏常数Km为0.09022 mM,最大反应速率为8.584 μmol/min,SA为1.335 U/mg(图2A,图2C),Fe-N-C@Hemin的米氏常数Km为0.05905 mM,最大反应速率Vmax为9.315 μmol/min,SA为8.829 U/mg(图2B,图2C),这说明Fe-N-C@Hemin的氧化酶活性要优于Fe-N-C。The enzyme kinetic parameters of the two nanozymes were fitted by the Michaelis-Menten equation. The results are shown in Figure 2. The Michaelis constant Km of Fe-N-C is 0.09022 mM, the maximum reaction rate is 8.584 μmol/min, and the SA is 1.335 U/min. mg (Figure 2A, Figure 2C), the Michaelis constant Km of Fe-N-C@Hemin is 0.05905 mM, the maximum reaction rate Vmax is 9.315 μmol/min, and SA is 8.829 U/mg (Figure 2B, Figure 2C), which shows that Fe The oxidase activity of -N-C@Hemin was better than that of Fe-N-C.
3、Fe-N-C@Hemin类氧化酶性质验证3. Verification of Fe-N-C@Hemin-like oxidase properties
对Fe-N-C@Hemin催化TMB显色的机理进行了初步探究,如图3A-B,分别在空气和氮气气氛下进行TMB显色实验,从图中可以看出,当在氮气气氛下检测时,其652 nm处吸光值大幅减弱,与空气下检测差异显著,这说明Fe-N-C@Hemin纳米酶催化TMB显色需要氧气的参与,进一步说明了Fe-N-C@Hemin的类氧化酶活性。The mechanism of TMB color development catalyzed by Fe-N-C@Hemin was preliminarily explored. As shown in Figure 3A-B, TMB color development experiments were carried out under air and nitrogen atmosphere respectively. It can be seen from the figure that when detected under nitrogen atmosphere, , the absorbance value at 652 nm was greatly weakened, which was significantly different from that detected in air, which indicated that the Fe-N-C@Hemin nanozyme catalyzed TMB color development requires the participation of oxygen, which further explained the oxidase-like activity of Fe-N-C@Hemin.
为了探究Fe-N-C@Hemin促使TMB显色的过程中产生何种自由基,选择三种荧光探针TA(图4A)、SOGC(图4B)、DHE(图4C)作为Fe-N-C@Hemin催化TMB氧化的自由基指示剂,分别用于检测•OH、1O2、。如图4A-图4C,相比于的对照组,Fe-N-C@Hemin组均呈现荧光探针对应波长的峰,说明Fe-N-C@Hemin能够催化溶解氧产生•OH、1O2、/>。In order to explore what kind of free radicals are produced during the color development of TMB by Fe-NC@Hemin, three fluorescent probes TA (Fig. 4A), SOGC (Fig. 4B) and DHE (Fig. 4C) were selected as the catalysts of Fe-NC@Hemin. The free radical indicator of TMB oxidation is used to detect • OH, 1 O 2 , . As shown in Figure 4A-Figure 4C, compared with the control group, the Fe-NC@Hemin group showed peaks corresponding to the wavelength of the fluorescent probe, indicating that Fe-NC@Hemin can catalyze dissolved oxygen to generate • OH, 1 O 2 , /> .
利用电子顺磁共振谱进行检测,以5,5-二甲基-1-氧化吡咯啉(DMPO)作为特异性探针捕获催化TMB显色过程中的反应中间体。如图5A,对应•OH的特征峰1:2:2:1;图5B对应1O2特征峰1:1:1;图5C显示为四大两小的六个峰,对应的特征峰,进一步证实了三种自由基的存在。Electron paramagnetic resonance spectroscopy was used for detection, and 5,5-dimethyl-1-pyrroline oxide (DMPO) was used as a specific probe to capture the reaction intermediates in the chromogenic process of catalytic TMB. As shown in Figure 5A, it corresponds to the characteristic peak of OH 1:2:2:1; Figure 5B corresponds to the characteristic peak of 1 O 2 1:1:1; Figure 5C shows six peaks of four big and two small, corresponding to The characteristic peaks further confirmed the existence of three free radicals.
为了探究在Fe-N-C@Hemin催化TMB反应过程中哪种自由基起主要作用,采用两种验证方式。首先使用荧光法,用活性氧荧光探针DCFH-DA作为标记信号,分别加入•OH、1O2、对应的三种自由基清除剂:异丙醇、叠氮化钠和超氧化物歧化酶,如图6所示,当加入三种活性氧清除剂时荧光均有减弱,其中,添加异丙醇时荧光降低量最多,与对照组相比降低了85.24%,说明•OH为最主要的反应中间体。同时利用比色法进行验证,在溶液中加入Fe-N-C@Hemin与TMB,添加自由基清除剂后吸光值均有显著下降,其中添加异丙醇时吸光度下降最为明显,与对照组相比降低了0.21,同样说明Fe-N-C@Hemin的氧化能力主要来源于•OH(图6A-B)。In order to explore which free radical plays a major role in the process of Fe-NC@Hemin catalyzed TMB reaction, two verification methods were adopted. Firstly, use the fluorescence method, use the active oxygen fluorescent probe DCFH-DA as the labeling signal, add OH, 1 O 2 , The corresponding three free radical scavengers: isopropanol, sodium azide and superoxide dismutase, as shown in Figure 6, when the three active oxygen scavengers are added, the fluorescence is weakened. Among them, adding isopropanol Fluorescence decreased the most when compared with the control group by 85.24%, indicating that • OH was the main reaction intermediate. At the same time, the colorimetric method was used to verify that Fe-NC@Hemin and TMB were added to the solution, and the absorbance value decreased significantly after adding free radical scavenger. Among them, the absorbance decreased most obviously when adding isopropanol, which was lower than that of the control group. 0.21, which also shows that the oxidation ability of Fe-NC@Hemin is mainly derived from • OH (Fig. 6A-B).
基于以上验证结果,推测Fe-N-C@Hemin的类氧化酶催化机理如下(图7):Fe-N-C@Hemin能够催化其表面所吸附的溶解氧,产生,/>在水溶液中极不稳定,会迅速反应生成H2O2和1O2,H2O2则与/>反应生成•OH,此外,Fe-N-C@Hemin也可由类芬顿反应直接催化H2O2生成/>和•OH。Based on the above verification results, it is speculated that the oxidase-like catalytic mechanism of Fe-NC@Hemin is as follows (Figure 7): Fe-NC@Hemin can catalyze the dissolved oxygen adsorbed on its surface to produce , /> Extremely unstable in aqueous solution, it will react quickly to form H 2 O 2 and 1 O 2 , and H 2 O 2 and /> The reaction generates OH. In addition, Fe-NC@Hemin can also directly catalyze the generation of H 2 O 2 by Fenton-like reaction/> and •OH.
实施例2 检测条件优化Example 2 Detection condition optimization
1、实验材料1. Experimental materials
3,3’,5,5’-四甲基联苯胺、谷胱甘肽、半胱氨酸,均购自市售产品。3,3',5,5'-Tetramethylbenzidine, glutathione, and cysteine were all purchased from commercially available products.
2、一种谷胱甘肽及半胱氨酸快速检测方法的条件优化2. Condition optimization of a rapid detection method for glutathione and cysteine
对谷胱甘肽及半胱氨酸进行检测,首先加入10 μL待测物于84 μL醋酸钠缓冲液中,后加入4 μL浓度为1 mg/mL的Fe-N-C@Hemin单原子纳米酶,最后加入TMB溶液,反应一定时间后测定其652 nm处吸光度,计算抑制率。分别对反应过程中的纳米酶浓度、TMB浓度、pH和反应时间进行了优化。To detect glutathione and cysteine, first add 10 μL of the test substance to 84 μL sodium acetate buffer, and then add 4 μL of Fe-N-C@Hemin single-atom nanozyme with a concentration of 1 mg/mL, Finally, add TMB solution, measure its absorbance at 652 nm after reacting for a certain period of time, and calculate the inhibition rate. The nanozyme concentration, TMB concentration, pH and reaction time during the reaction were optimized respectively.
结果如图8A所示,首先对纳米酶浓度进行优化,当纳米酶终浓度在10、20、30、40、50 μg/mL范围内时,随着纳米酶浓度的提高,显色趋势逐渐加深,当Fe-N-C@Hemin纳米酶终浓度为40 μg/mL的时候,显色最佳,因此最佳纳米酶终浓度为40 μg/mL;The results are shown in Figure 8A. Firstly, the concentration of nanozyme was optimized. When the final concentration of nanozyme was in the range of 10, 20, 30, 40, and 50 μg/mL, the color development trend gradually deepened with the increase of nanozyme concentration. , when the final concentration of Fe-N-C@Hemin nanozyme is 40 μg/mL, the color development is the best, so the optimal final concentration of nanozyme is 40 μg/mL;
在此浓度下探究TMB浓度对Fe-N-C@Hemin的OXD活性影响,选择终浓度为0、0.2、0.4、1、2、4、10 mM的TMB溶液,于37°C下反应15 min,结果如图8B,当TMB终浓度为0.4 mM的时候OD652 nm最高,因此TMB终浓度为0.4 mM时为最佳显色浓度;At this concentration, the effect of TMB concentration on the OXD activity of Fe-N-C@Hemin was explored. TMB solutions with final concentrations of 0, 0.2, 0.4, 1, 2, 4, and 10 mM were selected and reacted at 37°C for 15 min. The results were As shown in Figure 8B, when the final concentration of TMB is 0.4 mM, the OD652 nm is the highest, so when the final concentration of TMB is 0.4 mM, it is the best color development concentration;
反应体系的pH会影响纳米酶的催化能力,因此选择2.6、3.6、4.6、5.6、7.6、8.6为优化pH,探究该传感器最佳pH。pH对Fe-N-C@Hemin催化TMB的OXD活性影响如图8C,当pH为3.6时,OD652 nm吸光度之高,为0.60,随着pH升高,OD652 nm逐渐下降,说明Fe-N-C@Hemin在酸性条件下显色效果好于中性和偏碱性条件。The pH of the reaction system will affect the catalytic ability of the nanozyme, so 2.6, 3.6, 4.6, 5.6, 7.6, and 8.6 were selected as the optimal pH to explore the optimal pH of the sensor. The effect of pH on the OXD activity of TMB catalyzed by Fe-N-C@Hemin is shown in Figure 8C. When the pH is 3.6, the OD652 nm absorbance is as high as 0.60. As the pH increases, the OD652 nm gradually decreases, indicating that Fe-N-C@Hemin The color rendering effect under acidic conditions is better than that under neutral and alkaline conditions.
最后对显色时间进行优化,如图8D,随着时间的增加,显色逐渐增强,显色15min时已与5 min有较大差异,考虑到快速检测的需求,结合实验优化结果,故选择15 min为最佳反应时间。Finally, optimize the color development time, as shown in Figure 8D. As the time increases, the color development gradually increases, and there is a big difference between the color development time of 15 minutes and 5 minutes. Considering the needs of rapid detection and the experimental optimization results, we choose 15 min is the best response time.
实施例3 谷胱甘肽及半胱氨酸的特异性检测的验证Example 3 Verification of the specific detection of glutathione and cysteine
利用常见离子、蛋白等探究影响Fe-N-C@Hemin类OXD活性的物质有哪些,如图9,从图中可以看出半胱氨酸和谷胱甘肽能够显著抑制Fe-N-C@Hemin的类OXD活性,说明所构建从传感体系对谷胱甘肽及半胱氨酸的检测具有特异性。Use common ions, proteins, etc. to explore the substances that affect the activity of Fe-N-C@Hemin-like OXD, as shown in Figure 9, it can be seen from the figure that cysteine and glutathione can significantly inhibit the activity of Fe-N-C@Hemin-like OXD The OXD activity shows that the constructed sensor system has specificity for the detection of glutathione and cysteine.
实施例4 检测方法的灵敏度测定The sensitivity determination of embodiment 4 detection method
构建基于Fe-N-C@Hemin单原子纳米酶的传感器进行Cys和GSH的检测。取10 μL浓度为0、0.1、0.25、0.5、0.75、1 mM的Cys/GSH溶液,加入到84 μL的醋酸钠缓冲液中(pH=3.6)。然后加入4 μL浓度为1 mg/mL的Fe-N-C@Hemin单原子纳米酶,孵育5 min后,加入2 μL浓度为20 mM的TMB。继续在37°C下反应15 min。用酶标仪测定652 nm下的吸光度,抑制率计算公式为(A0-A)/A0×100,其中A0为不添加待测样品的一组。A sensor based on Fe-NC@Hemin single-atom nanozyme was constructed for the detection of Cys and GSH. Take 10 μL of Cys/GSH solutions with concentrations of 0, 0.1, 0.25, 0.5, 0.75, and 1 mM, and add them to 84 μL of sodium acetate buffer (pH=3.6). Then 4 μL of Fe-NC@Hemin single-atom nanozyme with a concentration of 1 mg/mL was added, and after incubation for 5 min, 2 μL of TMB with a concentration of 20 mM was added. Continue to react at 37°C for 15 min. The absorbance at 652 nm was measured with a microplate reader, and the inhibition rate was calculated as (A 0 -A)/A 0 ×100, where A 0 was a group without adding the sample to be tested.
如图10所示,对半胱氨酸和谷胱甘肽进行检测,通过LOD=3.3σ/s计算检测限,Cys在0.025~0.2 mM之间的线性回归方程为y=276.5x+23.48,检测限为0.513 μM、GSH在0.05~0.8 mM范围内的线性回归方程为y=60.53x+32.78,检测限LOD为3.1 μM。As shown in Figure 10, cysteine and glutathione were detected, and the detection limit was calculated by LOD=3.3σ/s, and the linear regression equation of Cys between 0.025 and 0.2 mM was y=276.5x+23.48, The detection limit is 0.513 μM, the linear regression equation of GSH in the range of 0.05~0.8 mM is y=60.53x+32.78, and the detection limit LOD is 3.1 μM.
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之做一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (10)
- Use of fe-N-c@hemin as oxidoreductase.
- 2. Use according to claim 1, for detecting the glutathione or cysteine content.
- 3. A kit for specifically detecting glutathione or cysteine, said kit comprising:Fe-N-C@Hemin, TMB and sodium acetate buffer solution.
- 4. The kit according to claim 3, wherein the working concentration of Fe-N-C@Hemin is 20-50 μg/mL; the working concentration of TMB is 0.2-0.5 mM; the pH of the sodium acetate buffer solution is 3-5.
- 5. Use of the kit according to claim 3 or 4 for detecting glutathione or cysteine content.
- 6. The application according to claim 5, wherein the specific application method is:1) Mixing a sample to be tested with a sodium acetate buffer solution, wherein the volume ratio of the sample to be tested to the sodium acetate buffer solution is 1:8-10;2) Adding Fe-N-C@Hemin monoatomic nano enzyme, and then adding TMB for reaction;3) The absorbance at 652 and nm was measured, the inhibition was calculated, a linear regression equation was constructed, and the concentration was calculated.
- 7. The use according to claim 6, wherein in step 2), the working concentration of Fe-N-c@hemin is 20-50 μg/mL; TMB has a working concentration of 0.2 to 0.5 mM.
- 8. The use according to claim 7, wherein the reaction time of step 2) is 10-20 min; the pH value of the reaction is 3-5.
- 9. The use according to claim 6, wherein the inhibition ratio calculation formula is (a 0 -A)/A 0 X 100, wherein A 0 A group to which no sample to be tested was added.
- 10. Use according to any one of claims 6 to 9, wherein the sample is food or serum, and wherein when the sample is serum, the use is for non-diagnostic purposes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310836084.1A CN116559102A (en) | 2023-07-10 | 2023-07-10 | Rapid detection method of glutathione and cysteine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310836084.1A CN116559102A (en) | 2023-07-10 | 2023-07-10 | Rapid detection method of glutathione and cysteine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116559102A true CN116559102A (en) | 2023-08-08 |
Family
ID=87500469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310836084.1A Pending CN116559102A (en) | 2023-07-10 | 2023-07-10 | Rapid detection method of glutathione and cysteine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116559102A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119118204A (en) * | 2024-05-14 | 2024-12-13 | 河南省人民医院 | Nanozyme and its preparation, detection, testing method and device and application |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110993970A (en) * | 2019-12-04 | 2020-04-10 | 河南大学 | Heme and pyridyl metalloporphyrin co-assembled nano material, preparation method and application thereof |
| US20210047741A1 (en) * | 2018-02-13 | 2021-02-18 | Gaznat Sa | Fe-N-C CATALYST, METHOD OF PREPARATION AND USES THEREOF |
| CN115282963A (en) * | 2022-08-08 | 2022-11-04 | 西北工业大学 | Monatomic catalyst taking biomass as precursor, preparation method and application thereof |
| US20230067623A1 (en) * | 2021-08-10 | 2023-03-02 | Wisconsin Alumni Research Foundation | Synthesis of atomically dispersed m-n-c catalysts via selective metalation |
| CN116380886A (en) * | 2023-06-05 | 2023-07-04 | 中国农业大学 | Method for intelligently detecting organophosphorus pesticide by double signals |
-
2023
- 2023-07-10 CN CN202310836084.1A patent/CN116559102A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210047741A1 (en) * | 2018-02-13 | 2021-02-18 | Gaznat Sa | Fe-N-C CATALYST, METHOD OF PREPARATION AND USES THEREOF |
| CN110993970A (en) * | 2019-12-04 | 2020-04-10 | 河南大学 | Heme and pyridyl metalloporphyrin co-assembled nano material, preparation method and application thereof |
| US20230067623A1 (en) * | 2021-08-10 | 2023-03-02 | Wisconsin Alumni Research Foundation | Synthesis of atomically dispersed m-n-c catalysts via selective metalation |
| CN115282963A (en) * | 2022-08-08 | 2022-11-04 | 西北工业大学 | Monatomic catalyst taking biomass as precursor, preparation method and application thereof |
| CN116380886A (en) * | 2023-06-05 | 2023-07-04 | 中国农业大学 | Method for intelligently detecting organophosphorus pesticide by double signals |
Non-Patent Citations (3)
| Title |
|---|
| LIHUA SHEN等: "Fe–N–C single-atom nanozymes based sensor array for dual signal selective determination of antioxidants", BIOSENSORS & BIOELECTRONICS, vol. 205, pages 1 - 6 * |
| WENDONG LIU等: "Hemin-assisted synthesis of peroxidase-like Fe-N-C nanozymes for detection of ascorbic acid-generating bio-enzymes", CHEMICAL ENGINEERING JOURNAL, vol. 415, pages 1 - 10 * |
| 宋光春等: "单原子纳米酶及其在食品检测中的研究进展", 食品科学, vol. 43, no. 11, pages 186 - 196 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119118204A (en) * | 2024-05-14 | 2024-12-13 | 河南省人民医院 | Nanozyme and its preparation, detection, testing method and device and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yuan et al. | Dual-signal uric acid sensing based on carbon quantum dots and o-phenylenediamine | |
| Yang et al. | A biosensor based on the biomimetic oxidase Fe3O4@ MnO2 for colorimetric determination of uric acid | |
| Zhang et al. | Copper sulfide nanoclusters with multi-enzyme-like activities and its application in acid phosphatase sensing based on enzymatic cascade reaction | |
| Xu et al. | A colorimetric/electrochemical dual-mode sensor based on Fe3O4@ MoS2-Au NPs for high-sensitivity detection of hydrogen peroxide | |
| CN109266332B (en) | Preparation method of ratiometric fluorescent probe for quantitatively detecting AChE and BChE in blood | |
| Ma et al. | Copper (II) ions enhance the peroxidase-like activity and stability of keratin-capped gold nanoclusters for the colorimetric detection of glucose | |
| CN119044085B (en) | A method for detecting glutathione based on Mn-CDs nanozyme colorimetric sensing technology | |
| Zhou et al. | Fluorescence detections of hydrogen peroxide and glucose with polyethyleneimine-capped silver nanoclusters | |
| CN115888811B (en) | Nanozyme material, preparation method and application thereof, and detection method of Pb2+ ions | |
| CN108801998B (en) | A method of the ratio fluorescent probe in detecting choline based on copper nano-cluster compound | |
| Zhang et al. | Fabrication of polyethyleneimine-functionalized reduced graphene oxide-hemin-bovine serum albumin (PEI-rGO-hemin-BSA) nanocomposites as peroxidase mimetics for the detection of multiple metabolites | |
| Hu et al. | A ratiometric fluorescence sensor for ultra-sensitive detection of trypsin inhibitor in soybean flour using gold nanocluster@ carbon nitride quantum dots | |
| Ahmed et al. | Strong nanozymatic activity of thiocyanate capped gold nanoparticles: an enzyme–nanozyme cascade reaction based dual mode ethanol detection in saliva | |
| CN114518344A (en) | ACP @ Ce/Tb-IPA ratio fluorescence and colorimetric dual-mode pesticide residue detection method | |
| Qi et al. | Au@ Pt nanozyme-based smart hydrogel for visual detection of hyaluronic acid | |
| Li et al. | A cholesterol optical fiber sensor based on CQDs-COD/CA composite | |
| CN112763484B (en) | Method for detecting glutathione and/or hydrogen peroxide based on colorimetric biosensor | |
| Yan et al. | Highly efficient persistent luminescent nanozymes-based luminescence-colorimetric dual-mode sensor for total antioxidant capacity assay | |
| Li et al. | Highly sensitive quantitative detection of glutathione based on a fluorescence-colorimetric dual signal recognition strategy | |
| Wang et al. | CeO2 nanocages with tetra-enzyme mimetic activities for dual-channel ratiometric colorimetric detection of microcystins-LR | |
| CN116559102A (en) | Rapid detection method of glutathione and cysteine | |
| CN115753649B (en) | A silicon-based Prussian blue nanozyme, preparation method and application thereof in colorimetric detection of glutathione | |
| Liu et al. | A label-free “turn-on” fluorescence platform for glucose based on AuNCs@ MnO 2 nanocomposites | |
| Wang et al. | Diacetyl as a new-type of artificial enzyme to mimic oxidase mediated by light and its application in the detection of glutathione at neutral pH | |
| Yang et al. | Bimetallic CuFe Prussian blue analogue cubes enhanced luminol chemiluminesence and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230808 |